Polarizing solution and intrathecal methylprednisolone acetate in multiple sclerosis: follow-up study.
D000328:Adult; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D007278:Injections, Spinal; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D011189:Potassium Chloride / Q000627:therapeutic use; D012996:Solutions / Q000627:therapeutic use*
D007328:Insulin; D012996:Solutions; D011189:Potassium Chloride; D005947:Glucose; D008775:Methylprednisolone